14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $64.00 $75.66 Thursday, 25th Apr 2024 CYTK stock ended at $64.80. This is 3.02% less than the trading day before Wednesday, 24th Apr 2024. During the day the stock fluctuated 2.22% from a day low at $64.00 to a day high of $65.42.
90 days $61.33 $84.05
52 weeks $25.98 $110.00

Historical Cytokinetics prices

Date Open High Low Close Volume
Oct 30, 2020 $15.44 $15.46 $14.91 $15.37 712 362
Oct 29, 2020 $15.41 $15.75 $14.89 $15.49 899 545
Oct 28, 2020 $15.75 $16.05 $15.26 $15.35 780 722
Oct 27, 2020 $15.66 $16.49 $15.41 $16.33 678 463
Oct 26, 2020 $16.22 $16.58 $15.35 $15.50 904 422
Oct 23, 2020 $16.20 $16.54 $15.90 $16.39 694 701
Oct 22, 2020 $15.75 $16.63 $15.74 $16.22 1 427 263
Oct 21, 2020 $16.15 $16.59 $15.52 $15.70 724 170
Oct 20, 2020 $16.60 $17.20 $16.20 $16.26 774 850
Oct 19, 2020 $16.55 $16.99 $16.45 $16.56 769 139
Oct 16, 2020 $16.25 $17.15 $16.21 $16.47 2 034 468
Oct 15, 2020 $16.35 $16.70 $15.85 $16.23 909 734
Oct 14, 2020 $16.90 $17.58 $16.33 $16.49 1 706 271
Oct 13, 2020 $15.64 $17.06 $15.58 $16.89 2 741 475
Oct 12, 2020 $15.12 $15.98 $14.71 $15.65 3 979 093
Oct 09, 2020 $16.12 $16.50 $15.01 $15.26 7 920 296
Oct 08, 2020 $17.45 $17.73 $15.16 $16.00 21 003 151
Oct 07, 2020 $28.54 $29.55 $27.61 $27.66 2 534 206
Oct 06, 2020 $29.04 $29.25 $27.83 $28.55 1 587 072
Oct 05, 2020 $26.33 $30.14 $26.26 $28.61 3 926 972
Oct 02, 2020 $22.15 $24.52 $21.54 $23.99 2 358 444
Oct 01, 2020 $21.79 $23.33 $21.57 $22.70 1 163 755
Sep 30, 2020 $22.49 $22.59 $21.26 $21.65 1 480 214
Sep 29, 2020 $22.27 $23.00 $22.24 $22.33 640 752
Sep 28, 2020 $23.75 $23.78 $22.11 $22.37 589 889
Click to get the best stock tips daily for free!

About Cytokinetics

Cytokinetics Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati... CYTK Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT